Paul Spoors

Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX.

Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members.

Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland.

H.J. Heinz Co. Ltd. produces, processes, and distributes food products. It also offers beans, sandwich spreads, fruit spreads, jams and jellies, cookies and cereal bars, spaghetti sauces, canned and microwave soups, ready entree meals, ready breakfasts, and canned & dry pasta products. The company was founded by Henry J. Heinz in 1917 and is headquartered in Hayes, the united Kingdom.

Part of Sanofi, Aventis Bio-Services, Inc. develops pharmaceutical and agricultural products. The company is based in King of Prussia, PA.

Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million.

Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom.

Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand (London) is a British company that provides accounting services. The company is based in Edinburgh, UK.

Capgemini America, Inc. engages in the provision of software solutions. It offers outsourcing, consulting, and digital transformation. The company is headquartered in New York, NY.

Thelin Co., Inc. manufactures wood, pellet and gas stoves. The firm’s products include hand made stoves. It also offers maintenance services. The company was founded by Thelin Thompson and Terry Thompson in 1978 and is headquartered in Grass Valley, CA.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Part of Oxford Biomedica Plc, Oxxon Therapeutics Ltd. is a biotechnology company. Oxxon Therapeutics Ltd. is based in Oxford, UK. Oxxon Therapeutics was acquired by Oxford Biomedica Plc on March 15, 2007 for $24.89 million. The British company was founded in 1998.

Part of Oxford Biomedica Plc, Oxford Biomedica (UK) Ltd. is a viral vector contract development and manufacturing organization (CDMO) based in Oxford, UK. Oxford Biomedica (UK has over 25 years of experience in the industry and is committed to enabling its clients to deliver life-changing therapies to patients worldwide. The British company offers innovative solutions to cell and gene therapy biotechnology and biopharma companies by working across key viral vector delivery systems including adeno-associated virus (AAV) and lentiviral delivery system.

Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom.

Part of Shield Therapeutics Plc, Shield TX (UK) Ltd. is a British pharmaceutical company founded in 2008. The company is based in Gateshead, UK. Shield TX (UK specializes in developing innovative specialty pharmaceuticals to address significant unmet needs in the treatment of iron deficiency. The company's clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make the difference in their everyday lives. Visitors can browse their library of results, reports, and presentations on their website and sign up for investor news alerts.

Banner Life Sciences LLC operates as clinical-stage pharmaceutical company. The company is headquartered in High Point, NC.

Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler.

The Association of Corporate Treasurers operates as an international professional body that specializes in the profession of corporate treasury. The firm offers education, training and grow network. It guides, informs and supports through technical work, webinars and publications. The company was founded in 1979 and is headquartered in London, the United Kingdom.

Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022.